China News--Chinese disputable scientist announced that he and his research team completed the research on tissue organ cloning and accomplished clinical application

China News reported on Aug. 16, 2007 (Reporter Sun Zifa). Rongxiang Xu, Chairman of Board Bureau and Director of Beijing Rongxiang Institue of Regenerative Medicine, MEBO International Group, announced to the public on Aug. 16, 2007 in Beijing, that he and his research team had completed the research on cloning more than 206 of tissue organs in experimental clinical practice and realized in situ defected human organ recovered clinically; also accomplished the controlling and transforming of the tumor cell lines as well.

Five years ago at the same day, Rongxiang Xu had made a commitment to the public that he and his team were going to complete the research on 206 of the tissue organ cloning and controlling and transforming the tumor cell line in a period of 5 years. The announcement, like a stone thrown into a calm water that caused a thousands scales of wave, had caused a great dispute, some positive, more negative. As a result, he was titled with the most disputed scientist. Rongxiang Xu said today's announcement, in one side, was to honor a commitment presented 5 years ago, in other side, was to make more people to understand the newest progresses in bio-life science.

In accordance with his presentation, the related techniques of tissue organ cloning have been granted 7 patents in USA, and 2 in Europe and Japan respectively. Now some patents are under reviewing in China and other countries. In addition, more patents, including platform of organ cloning filed in 2001 and other more applications, have been being reviewed and are expected to be obtained in the near future.

Xu, the most disputed scientist, had presented his bio-life science research plan, i.e. 1) By means of the matured techniques of tissue organ cloning in situ and the invented regenerative substances to realize defected organ recover in situ. To reach this goal, a number of hospitals, centering in Beijing, faced to whole world to engage in tissue organ cloning in situ in clinical practice will be established in whole China; 2) To establish a healthcare system based on regenerative recovery theory with regenerative nutrition to prevent human suffering from the diseases and aging. 3) Making every effort to conduct further research on the technique of defected inner organ recovered in regeneration with the technique of tissue organ cloning in situ and regenerative substances so that more and more doctors will provide better service to their patients with regenerative medicine and therapy. 4) It is expected to conduct further research on synthesis of various regenerative substances so as to develop more and more food combination of full-scale nutrition with regenerative nutrition, which are more convenient and cost effectively.

Rongxiang Xu's theory claimed that the life time of human beings should be at least 300 years. He said that he was going to approach and to verify the law of human longevity and to realize conclusion study in this field in his life time period so that the people in the world can enjoy the pleasure resulted from contribution of the achievement of life regenerative science to the human health.

As for the title of most disputed scientist, Rongxiang Xu frankly said that he likes dispute and will never been beaten down by it. He insists that scientific research, especially frontier of science needs more disputing and the process of find truth in disputing is to make more science progress.